Icon Plc(ICLR-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low162.83
Day High169.38
Open:165.10
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
Tipranks
SERAFA-1 Trial Update: AstraZeneca and Icon Deepen Their Breast Cancer Bet
Zacks Investment Research
ICON Stock and the CRO Trends Shaping Its Next Growth Phase
ICON Stock and the CRO Trends Shaping Its Next Growth Phase
Zacks Investment Research
Is ICLR Stock a Value Trap or Turnaround After an Earnings Reset?
Is ICLR Stock a Value Trap or Turnaround After an Earnings Reset?
Zacks Investment Research
ICON Stock Outlook 2026 as Margin Woes Meet a Stronger Backlog Base
ICON Stock Outlook 2026 as Margin Woes Meet a Stronger Backlog Base
Tipranks
Analysts Offer Insights on Healthcare Companies: ProMIS Neurosciences (PMN) and Icon (ICLR)
Tipranks
ICON plc Sets July 31, 2026 AGM and Seeks Expanded Capital Authorities
Tipranks
Analysts Offer Insights on Healthcare Companies: HCA Healthcare (HCA) and Icon (ICLR)
Tipranks
Jefferies Reaffirms Their Buy Rating on Icon (ICLR)
Tipranks
Analysts Offer Insights on Healthcare Companies: ARS Pharmaceuticals (SPRY), Gilead Sciences (GILD) and Icon (ICLR)
Tipranks
ICON plc Books Strong Q1 2026 Orders as Earnings Decline but Guidance Reaffirmed
Tipranks
ICON Reshapes Board, Refinances Debt and Divests Symphony Health in Q2 2026
Motley Fool
Why Icon Stock Crushed it on Wednesday
Tipranks
Analysts Offer Insights on Healthcare Companies: Abivax SA Sponsored ADR (ABVX), Icon (ICLR) and Liquidia Technologies (LQDA)
Tipranks
ICON Sets Dates for First-Quarter 2026 Earnings Release and Conference Call
Zacks Investment Research
ICON Stock Valuation vs Peers: Is ICLR Cheap Enough?
ICON Stock Valuation vs Peers: Is ICLR Cheap Enough?
Tipranks
SUNFLOWER Lupus Trial Puts AstraZeneca and ICON in Focus for Long‑Term Investors
Tipranks
Icon (ICLR) Receives a Buy from TD Cowen
Motley Fool
Grindr Stock Is Down 49%. Here's Why One Investor Added $15.9 Million
Motley Fool
Icon Public (ICLR) Q4 2025 Earnings Transcript

Profile

ICON plc is a global full service clinical research organisation. The company provides contract clinical research services to the pharmaceutical industry worldwide.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2026 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.